Is Suboxone Bad for Your Teeth? Decay and Prevention

Sublingual Suboxone (buprenorphine-naloxone) is associated with a measurably higher risk of tooth decay and tooth loss compared with other medications for opioid use disorder. A large cohort study of more than 30,000 people found that those taking sublingual buprenorphine-naloxone had roughly 70 percent more dental caries and tooth loss than those on oral naltrexone. The connection is real enough that the FDA updated buprenorphine’s label to include a dental warning in 2022, but the story is more layered than “Suboxone rots your teeth,” and the risk is manageable with the right habits.

What the Large-Scale Evidence Shows

The most important study on this topic looked at insurance claims for over 30,000 people taking one of three medications for opioid use disorder. The rate of dental caries or tooth loss among people on sublingual buprenorphine-naloxone was 8.2 per 1,000 person-years, compared with 3.5 per 1,000 person-years for transdermal buprenorphine (a skin patch) and 3.8 per 1,000 person-years for oral naltrexone. In adjusted analyses, the sublingual formulation carried a roughly 57 percent higher hazard compared with the patch and a roughly 71 percent higher hazard compared with naltrexone.¹ Those are relative increases, not absolute ones. In a separate study using a different dataset, the absolute risk of a dental adverse event among buprenorphine users was about 2.2 percent versus 1.7 percent in controls, translating to an adjusted hazard ratio of 1.36.²

Pharmacovigilance data from the FDA’s adverse-event reporting system paints an even more striking picture, though it measures reporting rates rather than true incidence. Sublingual and buccal buprenorphine were associated with roughly 15 times as many dental-problem reports as other buprenorphine formulations, and about 6 times as many as methadone.³ Adverse-event reports are influenced by how much attention a side effect gets, so the raw ratios overstate things. Still, the pattern is consistent: the sublingual route stands out.

Why the Sublingual Route Is the Problem

Not all buprenorphine products carry the same dental risk. A separate analysis of FDA adverse-event data found that dental disorder reporting was dramatically elevated for sublingual buprenorphine (about 20 times the background rate), elevated to a lesser degree for buccal and oral routes, and not elevated at all for transdermal patches or injectable formulations.⁴ That pattern points squarely at the way the drug is delivered rather than the drug molecule itself. When you hold a dissolving tablet or film under your tongue, it bathes your teeth and gums directly in the medication for several minutes.

The formulation itself is acidic. Case reports have measured the pH of dissolved buprenorphine-naloxone tablets at roughly 3.4 to 4.0, which is in the range of a soft drink or orange juice.⁵ Tooth enamel starts to dissolve at a pH of about 5.5, so repeated daily exposure to a solution that acidic, held against the teeth for minutes at a time, creates the kind of acid erosion that dentists normally see in people who sip citrus drinks all day. And unlike drinking a glass of juice, where saliva quickly washes the acid away, sublingual dosing requires you to keep the liquid pooled under your tongue until the drug is absorbed.

Buprenorphine’s Effect on Oral Bacteria

The acid erosion story alone would be enough to explain some extra cavities, but newer research has uncovered a second mechanism that may matter just as much. Buprenorphine appears to directly encourage the growth of the bacteria most responsible for tooth decay.

Streptococcus mutans is the main cavity-causing microbe in your mouth. Laboratory studies have shown that buprenorphine at concentrations found in saliva after a sublingual dose significantly boosts the amount of biofilm (the sticky bacterial film on teeth) that S. mutans produces, along with the sugary matrix the bacteria use to cement themselves to enamel.⁶ The effect held up not just in single-species lab cultures but also in mixed microbial communities grown from real human saliva, where buprenorphine-treated biofilms grew substantially thicker over 48 to 72 hours compared to untreated controls.⁶

Why is the drug still present in the mouth long after a dose dissolves? Research shows that buprenorphine accumulates in salivary gland tissue and is continuously secreted back into saliva. The resulting oral-fluid concentrations, in the range of 500 to 10,000 nanomolar, are high enough to sustain bacterial biofilm formation well beyond the few minutes the tablet is under your tongue.⁷ So even if you rinse your mouth immediately after dosing, buprenorphine continues to seep back into your oral environment throughout the day.

Dry Mouth Makes Everything Worse

Saliva is your mouth’s primary defense against cavities. It neutralizes acids, washes food debris off teeth, and delivers minerals that help repair early enamel damage. Opioids in general reduce saliva production, and buprenorphine is no exception. The case series that first flagged dental problems with sublingual buprenorphine identified chronic dry mouth as a likely contributor in all four patients, none of whom had significant dental disease before starting treatment.⁵

Dry mouth compounds every other risk factor. Without adequate saliva flow, the acid from the dissolving tablet lingers longer on enamel instead of being buffered away. The biofilm that buprenorphine helps S. mutans build is less likely to be mechanically disrupted by saliva’s natural rinsing action. And the minerals that would normally remineralize early lesions simply aren’t there in sufficient quantities. The combination of an acidic drug, enhanced bacterial biofilm, and reduced saliva creates a kind of perfect storm for rapid decay.

Confounding Factors That Complicate the Picture

It would be unfair to blame Suboxone for every cavity a person in opioid recovery develops. People entering treatment for opioid use disorder frequently arrive with dental health that has already taken a beating. Years of active addiction often mean skipped dental visits, poor nutrition, and heavy sugar consumption. Many people in recovery report intense cravings for sweet foods and sugary drinks, which are independent risk factors for cavities. Socioeconomic factors play a role too: research has noted that people in opioid treatment programs tend to have lower educational attainment and less stable housing compared to the general population, both of which are associated with worse dental outcomes.⁸

The JAMA cohort study tried to account for some of this by comparing sublingual buprenorphine users not against the general public but against people taking other medications for opioid use disorder, who presumably share many of the same lifestyle and socioeconomic risk factors. The fact that the sublingual route still came out worse in that comparison strengthens the case that something about the drug’s delivery method adds dental risk on top of whatever baseline risk comes with the territory of opioid recovery. Still, no observational study can fully separate the drug’s effect from everything else going on in a patient’s life, and researchers have acknowledged this limitation openly.

Steps You Can Take to Protect Your Teeth

Stopping Suboxone to save your teeth would be a bad trade for most people. The medication is highly effective at preventing relapse and overdose death, and the dental risk, while real, is manageable. The goal is to keep taking the medication while minimizing the damage it can do to your enamel.

The most commonly recommended protective strategy is straightforward. After your sublingual dose has fully dissolved, rinse your mouth gently with plain water and swallow. This helps clear residual acid and drug from your tooth surfaces. Wait at least one hour before brushing your teeth.⁹ The waiting period is important because your enamel is temporarily softened by the acid exposure, and brushing while enamel is soft can actually scrub it away faster. After that hour, brushing with a fluoride toothpaste is ideal.

Beyond the post-dose routine, a few broader strategies help:

Fluoride: Prescription-strength fluoride toothpaste or a fluoride rinse can speed up enamel remineralization. Some dentists recommend custom fluoride trays for high-risk patients.
Hydration: Staying well-hydrated and using sugar-free gum or lozenges with xylitol can stimulate whatever saliva production your body can still manage. Over-the-counter dry-mouth sprays and gels are another option.
Diet: Reducing sugary snacks and acidic drinks limits the food supply for cavity-causing bacteria and avoids piling more acid exposure on top of what the medication already delivers.
Regular dental visits: Professional cleanings and exams every six months, or more frequently if your dentist recommends it, can catch early decay before it becomes a major problem. If you are on sublingual buprenorphine, mention it to your dentist so they can watch for characteristic patterns of erosion.

Some providers have begun discussing alternative buprenorphine formulations with patients who have severe or worsening dental problems. The monthly injectable form (Sublocade) and the six-month implant (Probuphine) bypass the mouth entirely, eliminating the direct acid exposure and the local buildup of buprenorphine in saliva. These aren’t appropriate for everyone, and the sublingual form has dosing flexibility that injectables and implants lack, but they are worth discussing with your prescriber if dental damage is becoming serious.

Barriers to Dental Care in Recovery

Knowing you should see a dentist and actually getting into the chair are two different things. People in opioid recovery face a set of obstacles to dental care that go beyond money, though cost is certainly one of them. Qualitative research with patients on opioid maintenance therapy has identified anxiety and fear of dental procedures, difficulty keeping scheduled appointments, and gaps between what patients expect and what services are actually available as persistent barriers.¹⁰ Many patients also lack clear information about what dental services they are entitled to or how to navigate coverage.

Stigma adds another layer. Patients in recovery have described feeling judged or labeled in healthcare settings, including dental offices. While overtly discriminatory language from dental staff is uncommon, patients often perceive that they are being viewed through the lens of their addiction history, which discourages them from returning or from disclosing their medication use.¹¹ That nondisclosure is counterproductive, because a dentist who doesn’t know you’re on sublingual buprenorphine can’t tailor their prevention advice or monitoring accordingly.

On the provider side, many dentists have limited familiarity with opioid use disorder treatment and may not know what to recommend beyond standard oral hygiene advice. Better coordination between addiction treatment providers and dental professionals is something researchers and clinicians have consistently flagged as a gap that needs filling.

When the Damage Is Already Done

If you’ve been on sublingual Suboxone for years and already have significant decay, the question shifts from prevention to repair. The patterns of damage that dentists report in long-term sublingual buprenorphine users tend to concentrate on the lower front teeth and along the gumline, areas that get the most direct exposure when a tablet or film dissolves under the tongue. Decay in these areas can progress quickly because the enamel there is naturally thin.

Treatment options depend on severity. Early-stage erosion may respond to remineralization with fluoride and careful monitoring. More advanced cavities require fillings or crowns. In severe cases, teeth may be too damaged to save and extraction becomes necessary. Full or partial dentures, bridges, or dental implants are all options after extraction, though cost is a major consideration, especially since dental insurance coverage for people in substance use treatment is often inadequate.

If you and your prescriber decide to switch from a sublingual formulation to an injectable or implant form of buprenorphine, the existing dental damage won’t reverse on its own, but the acid exposure and local biofilm-promoting effects should stop, giving your mouth a better chance to stabilize with proper dental care going forward. The decision to switch formulations involves weighing dental health against dosing convenience, insurance coverage, and treatment stability, so it deserves a conversation with both your prescriber and your dentist rather than a unilateral decision based on your teeth alone.

Suboxone Versus Other Opioid Medications and Dental Risk

People sometimes wonder whether switching to methadone would be easier on their teeth. The pharmacovigilance data suggest sublingual buprenorphine is reported with dental problems about six times more often than methadone in adverse-event databases.³ But methadone carries its own well-documented dental risks: it is dispensed as a sweet liquid that coats the teeth, it causes significant dry mouth, and methadone clinics often report high rates of dental disease among their patients. The comparison is not as straightforward as the reporting ratios make it look. Methadone also comes with a different side-effect and safety profile, requires daily clinic visits in many programs, and carries a higher overdose risk if misused. Switching medications purely to protect your teeth, without considering the full clinical picture, is rarely recommended.

Oral naltrexone, the comparator in the JAMA study, had a lower rate of dental problems, but naltrexone works differently from buprenorphine. It blocks opioid receptors without activating them, so it doesn’t reduce cravings the same way and has higher dropout rates in real-world use. The “best” medication for opioid use disorder is the one that keeps you in treatment and alive, and for many people that is buprenorphine. The dental trade-off is worth knowing about and managing, but it rarely tips the scales away from treatment.